ACTIVE

Clinisys

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

14,2 M €

-72.9% YoY

Revenue

38,4 M €

-3.3% YoY

Equity

77,5 M €

+22.4% YoY

Workforce

99,8 ETP

-12.4% YoY

What does Clinisys do?

Clinisys is a Public limited company incorporated in 1985. Its main activity is: Other software publishing. Its registered office is in Gent. It employs on average 99,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0428.149.981

Incorporation

20/12/1985

Legal form

Public limited company

Registered office

Sluisweg 2 box 5
9000 Gent · FlandreSee on map

Contributed capital

5 103 744,18 €

Latest accounts

31/12/2025

Average workforce

99,8 ETP

Activities (NACE)

58290Other software publishing· main 58290Other software publishing 62010Computer programming activities 62100Computer programming, consultancy and related activities 72220Research and experimental development on social sciences and humanities

Joint committees (4)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 20 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Revenue	38,4 M €	-3.3%	39,7 M €	+9.2%	36,3 M €	-3.6%	37,7 M €	+6.4%	35,4 M €	+19.8%	29,6 M €	+16.8%	25,3 M €	+4.9%	24,1 M €	+8.6%	22,2 M €	+30.0%	17,1 M €	-12.7%	19,6 M €	+2.0%	19,2 M €	+4.6%	18,4 M €	+15.3%	15,9 M €	+7.6%	14,8 M €	-0.2%	14,8 M €	+22.3%	12,1 M €	-11.8%	13,8 M €	+15.0%	12 M €	-4.4%	12,5 M €
EBITDA	19,2 M €	+4.2%	18,4 M €	+18.3%	15,6 M €	-17.7%	18,9 M €	-7.4%	20,5 M €	+41.7%	14,4 M €	+33.3%	10,8 M €	-0.2%	10,8 M €	+12.7%	9,6 M €	+36.1%	7,1 M €	-1.3%	7,2 M €	+10.8%	6,5 M €	-10.2%	7,2 M €	+46.6%	4,9 M €	-10.4%	5,5 M €	+24.4%	4,4 M €	+59.0%	2,8 M €	-27.2%	3,8 M €	+38.4%	2,8 M €	-45.8%	5,1 M €
Operating result	19,4 M €	+10.4%	17,5 M €	+13.6%	15,4 M €	-17.7%	18,7 M €	-7.5%	20,3 M €	+42.4%	14,2 M €	+35.6%	10,5 M €	-25.3%	14,1 M €	+49.2%	9,4 M €	+35.9%	6,9 M €	-0.3%	6,9 M €	+10.6%	6,3 M €	-10.9%	7 M €	+43.4%	4,9 M €	-7.2%	5,3 M €	+27.6%	4,2 M €	+56.1%	2,7 M €	+1300%	189,9 k €	-92.8%	2,6 M €	-46.8%	5 M €
Net result	14,2 M €	-72.9%	52,3 M €	+354%	11,5 M €	-17.2%	13,9 M €	-1.7%	14,2 M €	+49.9%	9,4 M €	+55.1%	6,1 M €	-70.9%	20,9 M €	+322%	5 M €	+35.9%	3,7 M €	+8.3%	3,4 M €	+15.8%	2,9 M €	-11.9%	3,3 M €	+98.5%	1,7 M €	-20.0%	2,1 M €	+63.9%	1,3 M €	-19.3%	1,6 M €	+405%	311,4 k €	-82.3%	1,8 M €	-47.9%	3,4 M €
Balance sheet
Equity	77,5 M €	+22.4%	63,3 M €	-23.3%	82,6 M €	+16.2%	71,1 M €	+24.4%	57,1 M €	+33.0%	43 M €	+28.2%	33,5 M €	+22.2%	27,4 M €	+6.0%	25,9 M €	+23.7%	20,9 M €	+21.1%	17,3 M €	+24.3%	13,9 M €	+26.5%	11 M €	+43.0%	7,7 M €	+484%	1,3 M €	-85.0%	8,8 M €	+16.9%	7,5 M €	+26.5%	5,9 M €	+5.5%	5,6 M €	+45.8%	3,8 M €
Total assets	111,3 M €	+13.0%	98,6 M €	-15.5%	116,7 M €	+8.2%	107,9 M €	+13.5%	95,1 M €	+24.0%	76,7 M €	+13.3%	67,7 M €	+7.4%	63,1 M €	+5.0%	60 M €	+5.7%	56,8 M €	+6.7%	53,2 M €	+7.4%	49,5 M €	+3.7%	47,8 M €	+3.0%	46,4 M €	-0.7%	46,7 M €	+2.9%	45,4 M €	+4.2%	43,5 M €	+285%	11,3 M €	-17.6%	13,7 M €	+1.1%	13,6 M €
Cash	23,5 M €	+215%	7,5 M €	-75.0%	29,9 M €	+23.9%	24,1 M €	+503%	4 M €	-15.0%	4,7 M €	+45.8%	3,2 M €	+26.8%	2,5 M €	-70.1%	8,5 M €	+36.0%	6,3 M €	+128%	2,7 M €	+6.1%	2,6 M €	-41.2%	4,4 M €	+212%	1,4 M €	+64.7%	857 k €	+184%	302,1 k €	-77.1%	1,3 M €	+205%	432,4 k €	+31.8%	328,1 k €	-80.1%	1,6 M €
Debts	32,5 M €	+0.5%	32,3 M €	+0.8%	32,1 M €	-9.7%	35,5 M €	-3.2%	36,7 M €	+13.4%	32,4 M €	-1.6%	32,9 M €	-4.9%	34,6 M €	+4.7%	33 M €	-0.3%	33,1 M €	-2.8%	34,1 M €	+3.2%	33 M €	-4.3%	34,5 M €	-5.7%	36,6 M €	-15.8%	43,4 M €	+24.1%	35 M €	+1.0%	34,7 M €	+736%	4,1 M €	-42.2%	7,2 M €	-21.7%	9,2 M €
Other
Workforce	99,8 ETP	-12.4%	113,9 ETP	-9.4%	125,7 ETP	+1.5%	123,9 ETP	+10.2%	112,4 ETP	+2.3%	109,9 ETP	+4.5%	105,2 ETP	+4.4%	100,8 ETP	+3.6%	97,3 ETP	+6.9%	91,0 ETP	+7.1%	85,0 ETP	+9.0%	78,0 ETP	+6.7%	73,1 ETP	+7.0%	68,3 ETP	+10.2%	62,0 ETP	+9.0%	56,9 ETP	+7.4%	53,0 ETP	-11.1%	59,6 ETP	+19.2%	50,0 ETP	+15.2%	43,4 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 100 M€ and 250 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 29 ended

Active mandates

Andrew Branski

Director · since 31 octobre 2022 · until 12 juin 2028

Active

Michael Simpson

Director · since 31 octobre 2022 · until 12 juin 2028

Active

John Stipancich

bestuurder · since 10 juin 2022 · until 12 juin 2028

Active

Paul Van Overmeire

Managing director · since 10 juin 2022 · until 12 juin 2028

Active

Ended mandates

Andrew Hamish Darby

Director · since 10 juin 2022 · until 31 mars 2023

Ended

John Kenneth Stipancich

Director · since 10 juin 2022 · until 10 juin 2028

Ended

John Kenneth Stipancich

Director · since 10 juin 2022 · until 12 juin 2028

Ended

John Lebon

bestuurder · since 10 juin 2022 · until 30 avril 2024

Ended

At this address

Other companies at this address

Company	CBE no.
EMPWR● Active	0741.604.887
EMPWR Noble Participation Plan● Active	0791.559.095
EMPWR Nutrition Group● Active	0637.861.112
EMPWR Nutrition Participation Plan● Active	0791.878.997
HILLSIDE HOSPITALITY● Active	0775.971.690
Immo JHC● Active	1029.256.706
INTRUM NV● Active	0426.237.301
LA POSTERIE● Active	0825.861.661
Pacific Investments● Active	0818.989.608
Serinchamps Invest● Active	0802.215.536
SOJA Investments● Active	0774.739.790
WAHA INVEST● Active	0774.746.126

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	22/06/2026	23/06/2025	11/06/2024	28/06/2023	27/06/2022	19/07/2021
General meeting	10/06/2026	10/06/2025	10/06/2024	12/06/2023	10/06/2022	30/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	10/06/2026	22/06/2026	Dutch	PDF
Full model	31/12/2024	10/06/2025	23/06/2025	Dutch	PDF
Full model	31/12/2023	10/06/2024	11/06/2024	Dutch	PDF
Full model	31/12/2022	12/06/2023	28/06/2023	Dutch	PDF
Full model	31/12/2021	10/06/2022	27/06/2022	Dutch	PDF
Full model	31/12/2020	30/06/2021	19/07/2021	Dutch	PDF
Full model	31/12/2019	13/07/2020	29/07/2020	Dutch	PDF
Full modelCorrection	31/12/2018	13/07/2020	28/07/2020	Dutch	PDF
Full model	31/12/2018	24/06/2019	27/06/2019	Dutch	PDF
Full model	31/12/2017	29/06/2018	20/08/2018	Dutch	PDF
Full model	31/12/2016	12/06/2017	23/06/2017	Dutch	PDF
Full model	31/03/2016	12/09/2016	22/09/2016	Dutch	PDF
Full model	31/03/2015	10/09/2015	18/09/2015	Dutch	PDF
Full model	31/03/2014	10/09/2014	07/10/2014	Dutch	PDF
Full model	31/03/2013	10/09/2013	18/09/2013	Dutch	PDF
Full model	31/03/2012	26/11/2012	31/01/2013	Dutch	PDF
Full model	31/03/2011	12/09/2011	07/11/2011	Dutch	PDF
Full model	31/03/2010	10/09/2010	13/09/2010	Dutch	PDF
Full model	31/03/2009	10/09/2009	16/10/2009	Dutch	PDF
Full model	31/03/2008	10/09/2008	29/09/2008	Dutch	PDF
Full model	31/03/2007	10/09/2007	09/10/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 M€ and 250 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 4 active · 29 ended

Active mandates

Andrew Branski

Director · since 31 octobre 2022 · until 12 juin 2028

Active

Michael Simpson

Director · since 31 octobre 2022 · until 12 juin 2028

Active

John Stipancich

bestuurder · since 10 juin 2022 · until 12 juin 2028

Active

Paul Van Overmeire

Managing director · since 10 juin 2022 · until 12 juin 2028

Active

Ended mandates

Andrew Hamish Darby

Director · since 10 juin 2022 · until 31 mars 2023

Ended

John Kenneth Stipancich

Director · since 10 juin 2022 · until 10 juin 2028

Ended

John Kenneth Stipancich

Director · since 10 juin 2022 · until 12 juin 2028

Ended

John Lebon

bestuurder · since 10 juin 2022 · until 30 avril 2024

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates19/06/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates13/10/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/03/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates21/10/2022
ONTSLAGEN - BENOEMINGEN
PDF
Other09/09/2022
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - BENAMING
PDF
Other25/05/2021
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates18/05/2021
ONTSLAGEN - BENOEMINGEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202514,2 M €↓
2024
Annual accounts 202452,3 M €↑
2023
Annual accounts 202311,5 M €↓
12/06/2023
reconductionBaker Tilly Bedrijfsrevisoren BV — commissaris
06/02/2023
nominationPaul Van Overmeire — gedelegeerd bestuurder
2022
Annual accounts 202213,9 M €↓
31/10/2022
nominationAndrew Branski — bestuurder
31/10/2022
nominationMichael Simpson — bestuurder
10/06/2022
nominationPaul Van Overmeire — bestuurder
10/06/2022
reconductionJohn Lebon — bestuurder
10/06/2022
reconductionJohn Kenneth Stipancich — bestuurder
10/06/2022
reconductionAndrew Hamish Darby — bestuurder
2022
Name changeClinisys
2021
Annual accounts 202114,2 M €↑
2020
Annual accounts 20209,4 M €↑
2019
Annual accounts 20196,1 M €↓
2018
Annual accounts 201820,9 M €↑
2017
Annual accounts 20175 M €↑
2016
Annual accounts 20163,7 M €↑
2016
Annual accounts 20163,4 M €↑
2015
Annual accounts 20152,9 M €↓
2014
Annual accounts 20143,3 M €↑
2013
Annual accounts 20131,7 M €↓
2012
Annual accounts 20122,1 M €↑
2011
Annual accounts 20111,3 M €↓
2010
Annual accounts 20101,6 M €↑
2009
Annual accounts 2009311,4 k €↓
2008
Annual accounts 20081,8 M €↓
2007
Annual accounts 20073,4 M €
2007
Name changeMedical Information Professional Systems
20/12/1985
IncorporationPublic limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Clinisys

Overview

What does Clinisys do?

Trend over 20 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline